Big pharma is increasingly shopping in China to fill its pipelines as it faces looming patent cliffs on major blockbusters coupled with growing pricing pressures on drugs. As previously reported by ...

The U.S.-China tariff cuts, even if only for 90 days, address a major pain point: Christmas presents. Nearly one-fifth of U.S. retail sales last year came from the Christmas holiday season, according ...

Shipments of Chinese goods to the U.S. are plunging, auguring potential supply-chain disruptions that could empty store shelves as early as this summer, some experts have warned. As U.S. tariffs of up ...

NEW YORK (Reuters) -Prices for goods made in China and sold on Amazon.com have been rising faster than overall inflation, according to an analysis of 1,400 different products conducted exclusively for ...

China’s reported crackdown on falsely marketed imported supplements could favour ASX companies with verified Australian-made ...

Beijing released a statement on Monday attacking the EU’s strategy to supercharge local industry, arguing that the European ...